Your browser doesn't support javascript.
loading
The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine.
Liccioli, Giulia; Marrani, Edoardo; Giani, Teresa; Simonini, Gabriele; Barni, Simona; Mori, Francesca.
Affiliation
  • Liccioli G; Allergy Unit, Department of Pediatrics, University of Florence, Anna Meyer Children's University Hospital, Florence, Italy, giulialiccioli@gmail.com.
  • Marrani E; Rheumatology Unit, Department of Pediatrics, University of Florence, Anna Meyer Children's University Hospital, Florence, Italy.
  • Giani T; Rheumatology Unit, Department of Pediatrics, University of Florence, Anna Meyer Children's University Hospital, Florence, Italy.
  • Simonini G; Rheumatology Unit, Department of Pediatrics, University of Florence, Anna Meyer Children's University Hospital, Florence, Italy.
  • Barni S; Allergy Unit, Department of Pediatrics, University of Florence, Anna Meyer Children's University Hospital, Florence, Italy.
  • Mori F; Allergy Unit, Department of Pediatrics, University of Florence, Anna Meyer Children's University Hospital, Florence, Italy.
Pharmacology ; 104(1-2): 57-59, 2019.
Article in En | MEDLINE | ID: mdl-31067554
ABSTRACT

INTRODUCTION:

Acute generalized exanthematous pustulosis (AGEP) is a generalized, non-follicular sterile pustular rash, categorized as a severe cutaneous adverse reaction, which usually has a favorable prognosis. In a majority of cases (90%), AGEP is drug induced and different drugs are reported as cause of AGEP. Hydroxychloroquine (HCQ) is an antimalarial drug that is also used in some dermatologic and rheumatic diseases due to its immunosuppressive actions. Some cases of AGEP induced by HCQ are reported in literature but only in adults. MATERIALS, METHODS AND

RESULTS:

We describe the first case of AGEP caused by HCQ in a child affected by juvenile Sjögren syndrome. After withdrawal of HCQ and subsequent administration, the patient experienced the same cutaneous reaction. An allergy work-up was performed and patch test showed an ectopic flare of AGEP eruption.

CONCLUSION:

Our patient represents the first pediatric case of AGEP to HCQ, posing such a drug as a possible trigger also in children. Therefore, an accurate drug medical history is mandatory in order to rule out potential drug reactions when facing a sudden rash.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sjogren's Syndrome / Antirheumatic Agents / Acute Generalized Exanthematous Pustulosis / Hydroxychloroquine Type of study: Diagnostic_studies / Prognostic_studies Limits: Child / Female / Humans Language: En Journal: Pharmacology Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sjogren's Syndrome / Antirheumatic Agents / Acute Generalized Exanthematous Pustulosis / Hydroxychloroquine Type of study: Diagnostic_studies / Prognostic_studies Limits: Child / Female / Humans Language: En Journal: Pharmacology Year: 2019 Type: Article